On Monday, FibroGen Inc (NASDAQ: FGEN) opened lower -5.87% from the last session, before settling in for the closing price of $0.41. Price fluctuations for FGEN have ranged from $0.33 to $2.93 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -2.51% over the last five years. Company’s average yearly earnings per share was noted 65.07% at the time writing. With a float of $93.27 million, this company’s outstanding shares have now reached $98.77 million.
The firm has a total of 486 workers. Let’s measure their productivity.
FibroGen Inc (FGEN) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of FibroGen Inc is 7.10%, while institutional ownership is 58.89%. The most recent insider transaction that took place on Jun 12 ’24, was worth 25,884. In this transaction Chief Medical Officer of this company bought 22,123 shares at a rate of $1.17, taking the stock ownership to the 82,123 shares. Before that another transaction happened on Mar 07 ’24, when Company’s CEO bought 50,000 for $1.91, making the entire transaction worth $95,470. This insider now owns 470,178 shares in total.
FibroGen Inc (FGEN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 65.07% per share during the next fiscal year.
FibroGen Inc (NASDAQ: FGEN) Trading Performance Indicators
Check out the current performance indicators for FibroGen Inc (FGEN). In the past quarter, the stock posted a quick ratio of 1.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.71, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of FibroGen Inc (FGEN)
Analysing the last 5-days average volume posted by the [FibroGen Inc, FGEN], we can find that recorded value of 1.99 million was lower than the volume posted last year of 2.66 million. As of the previous 9 days, the stock’s Stochastic %D was 3.82%. Additionally, its Average True Range was 0.12.
During the past 100 days, FibroGen Inc’s (FGEN) raw stochastic average was set at 0.49%, which indicates a significant decrease from 1.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 255.11% in the past 14 days, which was higher than the 152.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9530, while its 200-day Moving Average is $1.1746. Now, the first resistance to watch is $0.4081. This is followed by the second major resistance level at $0.4311. The third major resistance level sits at $0.4487. If the price goes on to break the first support level at $0.3675, it is likely to go to the next support level at $0.3499. Should the price break the second support level, the third support level stands at $0.3269.
FibroGen Inc (NASDAQ: FGEN) Key Stats
There are currently 99,474K shares outstanding in the company with a market cap of 38.65 million. Presently, the company’s annual sales total 147,750 K according to its annual income of -284,230 K. Last quarter, the company’s sales amounted to 55,900 K and its income totaled -32,930 K.
